Finerenone for Cardiorenal Dysfunction Hypertension and chronic renal disease are frequently linked, and uncontrolled blood pressure can accelerate the progression of the disease. However, patients with type 2 diabetes and chronic kidney disease who take the nonsteroidal mineralocorticoid receptor antagonist finerenone experience considerably better cardiorenal outcomes. Updates on CPR and ACLS The field of resuscitation has advanced significantly over the past decades.
Cardiopulmonary resuscitation (CPR) was officially supported by the American Heart Association (AHA) in 1963, and by 1966, they had issued standardized CPR training guidelines for lay rescuers. Similarly, over the past few decades, recommendations for advanced cardiac life support (ACLS) have changed based on a combination of scientific evidence of varying strength and expert consensus. To gain detailed insights into…
